Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Meclofenamic acid sodium hydrate
Cat. No.:
OB0425LY-385
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Meclofenamic acid sodium hydrate is a hydrated form of meclofenamic acid, maintained for stability and absorption purposes.
Synonyms:
Sodium meclofenamate; Meclofenamate sodium hydrate; Meclomen; 67254-91-5; Monosodium N-(2,6-dichloro-m-tolyl)anthranilate monohydrate
CAS No.:
67254-91-5
Compound CID:
23663959
Formula:
C14H12Cl2NNaO3
Formula Weight:
336.15
Specification
Target:
Endogenous metabolite; Fat mass and obesity-associated protein (FTO); Potassium channel; Gap junction protein
Pathway:
Metabolic enzyme/Protease; Membrane transporter/Ion channel; Cytoskeleton
Storage:
Storage at -20°C.
Applications:
Meclofenamic acid sodium hydrate serves the same therapeutic roles as meclofenamic acid in inflammation and pain management research.
